Haemonetics Corp. buy BTIG Research
Start price
10.09.24
/
50%
€66.50
Target price
10.09.25
€101.52
Performance (%)
-32.03%
End price
11.09.25
€45.20
Summary
This prediction ended on 11.09.25 with a price of €45.20. The BUY prediction by BTIG_Research for Haemonetics Corp. performed very badly with a performance of -32.03%. BTIG_Research has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | -3.419% | -3.419% | - |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
-1.74%
30.01.26
30.01.26
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€72.00
09.01.26
09.01.26
€75.54
09.01.27
09.01.27
-21.53%
30.01.26
30.01.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€67.50
21.11.25
21.11.25
€76.29
21.11.26
21.11.26
-16.30%
30.01.26
30.01.26